{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:59:56Z","timestamp":1780592396900,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"DOI":"10.1186\/s12904-024-01538-9","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:02:43Z","timestamp":1724472163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia"],"prefix":"10.1186","volume":"23","author":[{"given":"Ari","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Notsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Fushiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotoe","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"1538_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7.","journal-title":"Lancet Oncol"},{"key":"1538_CR2","doi-asserted-by":"publisher","first-page":"601434","DOI":"10.1155\/2011\/601434","volume":"2011","author":"CL Donohoe","year":"2011","unstructured":"Donohoe CL, Ryan AM, Reynolds JV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011;2011:601434. https:\/\/doi.org\/10.1155\/2011\/601434.","journal-title":"Gastroenterol Res Pract"},{"key":"1538_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","volume":"3","author":"JM Argil\u00e9s","year":"2009","unstructured":"Argil\u00e9s JM, Busquets S, Toledo M, L\u00f3pez-Soriano FJ. The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care. 2009;3:263\u20138. https:\/\/doi.org\/10.1097\/SPC.0b013e3283311d09.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1538_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10:90\u20139. https:\/\/doi.org\/10.1038\/nrclinonc.2012.209.","journal-title":"Nat Rev Clin Oncol"},{"key":"1538_CR5","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/sj.bjc.6690590","volume":"80","author":"PT Todorov","year":"1999","unstructured":"Todorov PT, Field WN, Tisdale MJ. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361). Br J Cancer. 1999;80:1734\u20137. https:\/\/doi.org\/10.1038\/sj.bjc.6690590.","journal-title":"Br J Cancer"},{"key":"1538_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bjc.1991.188","volume":"63","author":"SA Beck","year":"1991","unstructured":"Beck SA, Tisdale MJ. Lipid mobilising factors specifically associated with cancer cachexia. Br J Cancer. 1991;63:846\u201350. https:\/\/doi.org\/10.1038\/bjc.1991.188.","journal-title":"Br J Cancer"},{"key":"1538_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754\u201362. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer"},{"key":"1538_CR8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","volume":"21","author":"O Wallengren","year":"2013","unstructured":"Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer. 2013;21:1569\u201377. https:\/\/doi.org\/10.1007\/s00520-012-1697-z.","journal-title":"Support Care Cancer"},{"key":"1538_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"S Von Haehling","year":"2010","unstructured":"Von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J cachexia Sarcopenia Muscle. 2010;1:1\u20135. https:\/\/doi.org\/10.1007\/s13539-010-0002-6.","journal-title":"J cachexia Sarcopenia Muscle"},{"key":"1538_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/s0959-8049(97)10090-9","volume":"34","author":"HJ Andreyev","year":"1998","unstructured":"Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34:503\u20139. https:\/\/doi.org\/10.1016\/s0959-8049(97)10090-9.","journal-title":"Eur J Cancer"},{"key":"1538_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","volume":"4","author":"VC Vaughan","year":"2013","unstructured":"Vaughan VC, Martin P, Lewandowski PA. Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle. 2013;4:95\u2013109. https:\/\/doi.org\/10.1007\/s13539-012-0087-1.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1538_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13539-014-0142-1","volume":"5","author":"JB Hopkinson","year":"2014","unstructured":"Hopkinson JB. Psychosocial impact of cancer cachexia. J Cachexia Sarcopenia Muscle. 2014;5:89\u201394. https:\/\/doi.org\/10.1007\/s13539-014-0142-1.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1538_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. East Coop Oncol Group Am J Med. 1980;69:491\u20137. https:\/\/doi.org\/10.1016\/s0149-2918(05)80001-3.","journal-title":"East Coop Oncol Group Am J Med"},{"key":"1538_CR14","doi-asserted-by":"publisher","first-page":"693458","DOI":"10.1155\/2009\/693458","volume":"2009","author":"KM Fox","year":"2009","unstructured":"Fox KM, Brooks JM, Gandra SR, et al. Estimation of Cachexia among Cancer patients based on four definitions. J Oncol. 2009;2009:693458. https:\/\/doi.org\/10.1155\/2009\/693458.","journal-title":"J Oncol"},{"key":"1538_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","volume":"67","author":"L Sun","year":"2015","unstructured":"Sun L, Quan X-Q, Yu S. An epidemiological survey of Cachexia in Advanced Cancer patients and Analysis on its Diagnostic and Treatment Status. Nutr Cancer. 2015;67:1056\u201362. https:\/\/doi.org\/10.1080\/01635581.2015.1073753.","journal-title":"Nutr Cancer"},{"key":"1538_CR16","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1002\/cncr.32406","volume":"125","author":"S Hamauchi","year":"2019","unstructured":"Hamauchi S, Furuse J, Takano T, et al. A multicenter, open-label, single\u2010arm study of anamorelin (ONO\u20107643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer. 2019;125:4294\u2013302. https:\/\/doi.org\/10.1002\/cncr.32406.","journal-title":"Cancer"},{"key":"1538_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"1538_CR18","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute."},{"key":"1538_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"key":"1538_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s00595-022-02493-9","volume":"52","author":"T Namikawa","year":"2022","unstructured":"Namikawa T, Marui A, Yokota K, et al. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients. Surg Today. 2022;52:1560\u20137. https:\/\/doi.org\/10.1007\/s00595-022-02493-9.","journal-title":"Surg Today"},{"key":"1538_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00520-020-05479-w","volume":"29","author":"M Fukahori","year":"2021","unstructured":"Fukahori M, Shibata M, Hamauchi S, et al. A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patients. Support Care Cancer. 2021;29:341\u20138. https:\/\/doi.org\/10.1007\/s00520-020-05479-w.","journal-title":"Support Care Cancer"},{"key":"1538_CR22","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1007\/s00520-020-05346-8","volume":"28","author":"S Mitsunaga","year":"2020","unstructured":"Mitsunaga S, Kasamatsu E, Machii K. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma. Support Care Cancer. 2020;28:5271\u20139. https:\/\/doi.org\/10.1007\/s00520-020-05346-8.","journal-title":"Support Care Cancer"},{"key":"1538_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","volume":"124","author":"M Kordes","year":"2021","unstructured":"Kordes M, Larsson L, Engstrand L, L\u00f6hr J-M. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer. 2021;124:1623\u201336. https:\/\/doi.org\/10.1038\/s41416-021-01301-4.","journal-title":"Br J Cancer"},{"key":"1538_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2169\/internalmedicine.0730-22","volume":"62","author":"T Takeda","year":"2023","unstructured":"Takeda T, Sasaki T, Okamoto T, et al. Impact of the extent of weight loss before Administration on the efficacy of Anamorelin in Advanced Pancreatic Cancer patients with Cachexia. Intern Med. 2023;62:1887\u201393. https:\/\/doi.org\/10.2169\/internalmedicine.0730-22.","journal-title":"Intern Med"},{"key":"1538_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-024-02546-8","author":"K Ando","year":"2024","unstructured":"Ando K, Naito T, Hamauchi S, et al. The efficacy and safety of anamorelin among patients with diabetes. Int J Clin Oncol. 2024. https:\/\/doi.org\/10.1007\/s10147-024-02546-8.","journal-title":"Int J Clin Oncol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-024-01538-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:03:42Z","timestamp":1724472222000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-024-01538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1538"],"URL":"https:\/\/doi.org\/10.1186\/s12904-024-01538-9","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were performed according to the ethical standards of the National Research Committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Shizuoka Cancer Center Institutional Review Board (Approval No. J2022-136-2022-1-3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}